These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8130888)

  • 41. Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).
    Sørensen HA; Schwarz P; Hyldstrup L; Transbøl I
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):309-15. PubMed ID: 8187293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of alpha-calcidiol (1 alpha-hydroxy-cholecalciferol) on the serum levels of osteocalcin in involutional osteoporosis].
    Pedrazzoni M; Ciotti G; Davoli L; Vescovi PP; Ianes A; Costi D; Santini T; Ulietti V; Passeri M
    Minerva Endocrinol; 1989; 14(4):207-11. PubMed ID: 2636697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of calcitriol in treating glucocorticoidinduced osteoporosis in patients with nephrotic syndrome: an open-label, randomized controlled study.
    Chen Y; Wan JX; Jiang DW; Fu BB; Cui J; Li GF; Chen CM
    Clin Nephrol; 2015 Nov; 84(5):262-9. PubMed ID: 26396095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skeletal responsiveness to endogenous parathyroid hormone in postmenopausal osteoporosis.
    Ebeling PR; Jones JD; Burritt MF; Duerson CR; Lane AW; Hassager C; Kumar R; Riggs BL
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1033-8. PubMed ID: 1400868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of a short course of oral phosphate treatment on serum parathyroid hormone(1-84) and biochemical markers of bone turnover: a dose-response study.
    Brixen K; Nielsen HK; Charles P; Mosekilde L
    Calcif Tissue Int; 1992 Oct; 51(4):276-81. PubMed ID: 1422972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.
    Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ
    Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences.
    Hardy-Yverneau P; Shenouda M; Moriniere P; Legallais C; Brazier M; Achard J; Fournier A
    Clin Nephrol; 1998 Oct; 50(4):236-46. PubMed ID: 9799069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
    Ooms ME; Lips P; Roos JC; van der Vijgh WJ; Popp-Snijders C; Bezemer PD; Bouter LM
    J Bone Miner Res; 1995 Aug; 10(8):1177-84. PubMed ID: 8585420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of infusion of parathyroid hormone and primary hyperparathyroidism on formation and breakdown of type I collagen.
    Brahm H; Ljunggren O; Larsson K; Lindh E; Ljunghall S
    Calcif Tissue Int; 1994 Dec; 55(6):412-6. PubMed ID: 7895178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamics of parathyroid hormone release and serum calcium regulation after surgery for primary hyperparathyroidism.
    Graf W; Rastad J; Akerström G; Wide L; Ljunghall S
    World J Surg; 1992; 16(4):625-31. PubMed ID: 1413832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of parathyroid function on serum bone Gla protein.
    Yoneda M; Takatsuki K; Yamauchi K; Oiso Y; Kurokawa M; Kawakubo A; Torimoto Y; Funahashi H; Tomita A
    Endocrinol Jpn; 1988 Feb; 35(1):39-45. PubMed ID: 3260859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism.
    Lind L; Wengle B; Sørensen OH; Wide L; Akerström G; Ljunghall S
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):250-6. PubMed ID: 2644746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of high dose pulse oral calcitriol on secondary hyperparathyroidism in patients with end-stage renal disease].
    Yang J; Luo N; Liang J
    Zhonghua Nei Ke Za Zhi; 1996 Feb; 35(2):89-91. PubMed ID: 9275624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2.
    Mornière P; Maurouard C; Boudailliez B; Westeel PF; Achard JM; Boitte F; el Esper N; Compagnon M; Maurel G; Bouillon R
    Nephron; 1992; 60(2):154-63. PubMed ID: 1552999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-related osteoporosis in Chinese: an evaluation of the response of intestinal calcium absorption and calcitropic hormones to dietary calcium deprivation.
    Kung AW; Luk KD; Chu LW; Chiu PK
    Am J Clin Nutr; 1998 Dec; 68(6):1291-7. PubMed ID: 9846861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
    Akiba T; Marumo F; Owada A; Kurihara S; Inoue A; Chida Y; Ando R; Shinoda T; Ishida Y; Ohashi Y
    Am J Kidney Dis; 1998 Aug; 32(2):238-46. PubMed ID: 9708607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism.
    Hulter HN; Halloran BP; Toto RD; Peterson JC
    J Clin Invest; 1985 Aug; 76(2):695-702. PubMed ID: 3928683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
    LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
    N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.